Ikarian Capital »

Galectin Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.8M 1.0M 2.75

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Galectin Therapeutics

Vanguard Group
BlackRock
BlackRock
Affinity Asset Advisors
Advisor Group Holdings
Ikarian Capital
Geode Capital Management
Commonwealth Equity Services
Sontag Advisory
Geneos Wealth Management
Susquehanna International
Northern Trust
State Street Corporation
Morgan Stanley
Atria Wealth Solutions

View all funds holding Galectin Therapeutics